$BFRG

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (6m)

—

Win rate (6m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 2, 4:45 PM ET

$BFRGr/pennystocksDDbullish

u/Marketspike · 5h ago12 prior · 100% at 3mo

Three Clobbered Stocks With Potential Catalysts for a Rebound: BFRG, RCAT & SKYX

BullFrog AI's AI platform for biotech drug discovery and clinical trial optimization is undervalued at $0.50 with ~$6.9M cash and minimal market cap. Upcoming revenue catalysts from pharmaceutical partnerships (including a top-five pharma company) could drive a rebound.

At post $0.50Now $0.50+0.1% since postedas of Nov 2, 4:45 PM ET

original post →

$BFRGr/pennystocksStock Infobullish

u/hestebid · 154d agono track record yet

Long BFRG

BFRG: Why BullFrog AI Might Be One of the Most Undervalued AI Healthcare Plays

BullFrog AI is transitioning from story stock to commercial execution with expanding sales operations, Top-5 pharma validation, and runway into 2027. At a $14M market cap, the company appears undervalued given its commercial-stage products, pharma partnerships, and potential to convert ongoing discussions into additional contracts.

At post $0.77Now $0.50-35.5% since postedas of Nov 2, 4:45 PM ET

1d-5.2%

3d-12.9%

1w-13.1%

1m-9.1%

3m-30.5%

6m—

1y—

original post →

End of results.